TERT promoter mutations and long-term survival in patients with thyroid cancer
- Tae Hyuk Kim1,*,
- Young-Eun Kim2,*,
- Soomin Ahn3,*,
- Ji-Youn Kim4,
- Chang-Seok Ki5,
- Young Lyun Oh3,
- Kyunga Kim6,
- Jae Won Yun7,8,
- Woong-Yang Park7,8,
- Jun-Ho Choe9,
- Jung-Han Kim9,
- Jee Soo Kim9,
- Sun Wook Kim1 and
- Jae Hoon Chung1⇑
- 1Division of Endocrinology and Metabolism, Department of Medicine, Thyroid Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
- 2Green Cross Genome, Yongin, Korea
- 3Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
- 4Center for Clinical Medicine, Samsung Biomedical Research Institute, Samsung Medical Center, Seoul, Korea
- 5Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
- 6Biostatistics and Clinical Epidemiology Center, Research Institute for Future Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
- 7Samsung Genome Institute, Samsung Medical Center, Seoul, Korea
- 8Department of Molecular Cell Biology, Sungkyunkwan University School of Medicine, Suwon, Korea
- 9Division of Breast and Endocrine Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
- Correspondence should be addressed to J H Chung; Email: thyroid{at}skku.edu
- © 2016 Society for Endocrinology